Evaluating targeted therapies in ovarian cancer metabolism: Novel role for pcsk9 and second generation mtor inhibitors

Dafne Jacome Sanz, Juuli Raivola, Hanna Karvonen, Mariliina Arjama, Harlan Barker, Astrid Murumägi, Daniela Ungureanu

Research output: Contribution to journalArticleScientificpeer-review

13 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Evaluating targeted therapies in ovarian cancer metabolism: Novel role for pcsk9 and second generation mtor inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences